1. Class I HDAC inhibitors enhance YB‐1 acetylation and oxidative stress to block sarcoma metastasis. (31st October 2019) Authors: El‐Naggar, Amal M; Somasekharan, Syam Prakash; Wang, Yemin; Cheng, Hongwei; Negri, Gian Luca; Pan, Melvin; Wang, Xue Qi; Delaidelli, Alberto; Rafn, Bo; Cran, Jordan; Zhang, Fan; Zhang, Haifeng; Colborne, Shane; Gleave, Martin; Mandinova, Anna; Kedersha, Nancy; Hughes, Christopher S; Surdez, Didie... Journal: EMBO reports Issue: Volume 20:Number 12(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗